Stay updated on Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial

Sign up to get notified when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T00:35:45.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    35 days ago
    Change Detected
    Summary
    Added site revision tag v3.4.2 and removed the earlier government-funding notice; this is an administrative update and does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T14:18:40.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    A site-wide notice about government funding lapses was added, with guidance to check cc.nih.gov and opm.gov for current status. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T10:25:56.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    UI and metadata updates include a glossary toggle label, updated QC-related labels, No FEAR Act data text, and a revision/version change to v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T06:11:54.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4 on the page footer. This change does not affect the study details, eligibility criteria, outcomes, or any user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:09:07.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Footer updates add Revision: v3.3.3 and remove HHS Vulnerability Disclosure and Revision: v3.3.2 from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T21:00:10.000Z thumbnail image

Stay in the know with updates to Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sofosbuvir/Velpatasvir vs Ribavirin in HCV Clinical Trial page.